摘要
目的初步研究湖北人群中CYP2D6基因的多态性,为后续的应用研究打下基础。方法采集137例志愿者静脉血,采用限制性片段长度多态性聚合酶链反应(PCR-RFLP)法分析CYP2D6*10基因多态性,测序法验证结果,哈迪-温伯格平衡定律检测基因型分布,卡方检验进行验证,并将结果和以往文献相比较。结果经测序验证,137例样本中,野生型(CC)为35例,出现频率为25.5%;杂合子(CT)为52例,出现频率为38.0%;突变型(TT)为50例,出现频率为36.5%,C等位基因的频率为44.5%,T等位基因的频率为55.5%,和以往研究结果相比,差异无统计学意义(P>0.05)。结论湖北人群中CYP2D6*10存在较高突变频率,在人群中开展基因分型对正确指导临床用药十分有必要。
Objective To preliminary study the distribution of CYP2 D6 polymorphism in Hubei population,with the intention of solid base for further applied research.Methods Venous blood was collected from137 volunteers,analysed CYP2 D6 * 10 Gene Polymorphism by using polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP)method.genotypes can be distinguished by agarose gel electrophoresis and gene sequencing.Hardy-Weinberg equilibrium law could be used to detect whether the genotype distribution was balanced,and chi-square test was used for verification,and the results were compared with the previous literature.Results Among the 137 samples,wild type(CC)was 35,the frequency was 25.5%.Heterozygote(CT)was 52,the frequency was 38.0%.And mutant(TT)was 50,the frequency was 36.5%.Also,C allele frequency was 44.5% while the T allele was 55.5%.There was no statistical difference compared with previous studies(P〉0.05).Conclusion Since there is a high mutation frequency of CYP2 D6*10 in Hubei population,it is very necessary to carry out genotyping to guide clinical medication correctly.
作者
曾嵘
毛晓兵
刘湘
黄婧
ZENG Rong;MAO Xiaobing;LIU Xiang;HUANG Jing(School of Laboratory Medicine,Hubei University of Chinese Medicine,Wuhan,Hubei 430065,Chin)
出处
《国际检验医学杂志》
CAS
2018年第13期1540-1542,1546,共4页
International Journal of Laboratory Medicine
基金
中国博士后科学基金面上项目(2014M552023)
湖北省自然科学基金面上项目(2014CFB220)